Andrew Worland – Managing Director and Chief Executive Officer – International Graphite (ASX:IG6) is building Australia’s capability in critical battery minerals and establishing a new ethical supply of battery anode graphite to support the global revolution in clean energy.
Copyright 2023 – Finance News Network
Source: Finance News Network
25 Nov 2019 - Lepidico (ASX:LPD) Managing Director, Joe Walsh provides an update on drill results from its recently acquired Rubicon and Helikon deposits in Namibia, L-Max Pilot Plant trial results and outlook.
Read More01 Jul 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses market outlook and which sectors and stocks do well in a downturn.
Read More08 Aug 2023 - WT Financial Group Limited (ASX:WTL) Managing Director Keith Cullen discusses drivers of profitability, the effect of lower adviser numbers in the industry and opportunities moving forward.
Read More02 Jun 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell talks about the company's antimicrobial wound gel BlastX, and its health benefits for the treatment of chronic wounds and ulcers.
Read More21 Sep 2023 - Alex Parks - CEO and Managing Director - Prominence Energy (ASX:PRM) is an ASX listed oil and gas exploration and development company.
Read More03 Mar 2023 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig discusses the company's half-year financial results, commenting on key drivers, the Lasoo platform launch, the Ovato acquisition and the company's partnership with Iberdrola.
Read More20 Nov 2023 - ABX Group (ASX:ABX) Managing Director Mark Cooksey speaks about rare earth resources, advancing sustainable aluminum production with promising growth for investors in the coming months.
Read More01 Jul 2021 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO & Managing Director Dr Michael Baker discusses the company's acquisition of the invariant natural killer T (iNKT) cell therapy platform from Imperial College London.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More
